Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

Clinical trial NCT01064440 · COMPLETED

Trial details

NCT number: NCT01064440
Sponsor: Helixmith Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Critical Limb Ischemia

Start date: 2010-07-09
Primary completion: 2013-08-05
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.